Guide: WHO R&D Good Participatory Practice for COVID-19 clinical trials: a toolboxby Mesh Editorial Team
This toolbox was developed in 2020 for the World Health Organisation COVID-19 Research Roadmap and provides a synthesis of key action points from the WHO GPP-EP guidelines. This “how to” guide gives an overview, tips and resources and will be updated as new resources are completed and approved.
Guide: WHO Working with Community Advisory Boards for COVID-19 related clinical studiesby World Health Organisation, Mesh Editorial Team
This toolbox was developed for the World Health Organisation COVID-19 Research Roadmap and shares information on establishing and working with different types of Community Advisory Boards/Groups (CAB/Gs) in the context of COVID-19 clinical studies.
This tool, developed by the site staff of the Microbicide Development Program in Tanzania, can be used to help community, trial participants, or staff members, prioritize issues and concerns central to the trial. This tool can serve as a platform to generate a list of potential issues and provide direction for what or which issues should take priority at the research site.
Using this tool, participants can raise and explore issues they perceive as priorities in HIV prevention research; discovering links between them. An interactive and fun way for community members and participants to be involved with the planning of HIV prevention research at the site.
The GPP Trial Site Binder is a companion tool to the Good Participatory Practice guidelines that research teams can use to help develop, organize and document the stakeholder engagement activity at the site. The binder is is divided into sixteen sections aligned with the guidelines. Each section contains key steps to help research staff follow the practices, templates for documenting and planning activities, and a place to file draft documents.
The GPP Blueprint is a companion to the Good Participatory Practice guidelines for biomedical HIV prevention research. It is a step-by-step guide designed for the research team members in charge of stakeholder engagement. It presents questions, worksheets and explanations that can guide and generate a stakeholder engagement plan for a specific trial or research program.
These offer an at-a-glance look at the GPP guidelines for individuals who may not be primarily responsible for implementing GPP, but who need to understand them. They are organized according to the stages of the trial life cycle: planning, trial conduct and post-trial. Each stage outlines GPP topic areas, highlights key practices, and lists considerations for various stakeholders